Cycurion, Inc. Adjourns Special Meeting of Stockholders: Key Investor Highlights
Cycurion, Inc. Adjourns Special Stockholder Meeting: Investor Details and Implications
MCLEAN, Va., Feb. 26, 2026 – Cycurion, Inc. (NASDAQ: CYCU), a leader in IT cybersecurity solutions, has announced the adjournment of its special meeting of stockholders originally scheduled for February 26, 2026. The meeting has been rescheduled for March 19, 2026, at 12:00 p.m. Eastern Time, providing shareholders additional time to cast their votes.
Key Points for Investors
-
Reason for Adjournment:
- The special meeting was postponed because the number of votes cast was less than the quorum required to conduct official business.
-
Purpose of the Meeting:
- Shareholders are to vote on the approval, pursuant to Nasdaq Listing Rule 5635(d), of the issuance of up to 3,314,920 shares of common stock upon the exercise of certain warrants issued in connection with a private placement completed on December 5, 2025.
- This potential issuance may equal or exceed 20% of Cycurion’s outstanding shares prior to the offering—a threshold that typically triggers shareholder approval requirements and can impact control and dilution.
-
Record Date and Voting:
- The record date remains January 21, 2026. Only shareholders of record as of this date are eligible to vote at the reconvened meeting.
- Proxies previously submitted remain valid for the rescheduled meeting unless revoked.
- Shareholders who have not voted are urged to do so promptly. Instructions are provided in the definitive proxy statement filed with the SEC on February 2, 2026. For voting assistance, shareholders can contact Cycurion’s proxy solicitor, D.F. King & Co., Inc.
-
Company Overview:
- Cycurion is a McLean, Virginia-based provider of IT cybersecurity and AI-powered solutions, with a focus on program management and business continuity. Its ARx platform and expert team serve government, healthcare, and corporate clients globally.
Shareholder Impact & Price-Sensitive Information
-
Potential Share Dilution: The approval of the proposal would authorize Cycurion to issue a substantial number of new shares—up to 3,314,920—which could lead to significant dilution for existing shareholders. This is a material event that could influence the company’s stock price.
-
Strategic Funding Implications: The warrants in question were issued as part of a recent private placement, signaling ongoing efforts to raise capital for growth and possibly fund acquisitions or operations.
-
Quorum Challenge: The failure to reach a quorum underscores potential shareholder disengagement or controversy around the proposal, which may reflect concerns about dilution or the company’s strategic direction.
Forward-Looking Statements & Risks
-
The company’s press release contains numerous forward-looking statements regarding its business growth, use of proceeds from the private placement, and potential acceleration of its inorganic growth strategy.
-
Risks: All forward-looking statements are subject to significant risks and uncertainties, including outcomes of ongoing investigations, potential legal proceedings, and the future performance of Cycurion’s stock. These risks are detailed in Cycurion’s filings with the SEC.
-
Cycurion does not undertake to update forward-looking statements except as required by law.
Contact Information
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review all relevant SEC filings and consult their financial advisors before making any investment decisions. The information herein is based on the company’s public disclosures as of February 26, 2026, and may be subject to change.
View Cycurion, Inc. Historical chart here
